Diabetic Patient Case Study

Total Length: 2064 words ( 7 double-spaced pages)

Total Sources: 10

Page 1 of 7

Question a. Is his current therapy working? (350 words) (20 marks) Justify your answer by using the evidence presented in the case study. In your answer, you should also explain the pathophysiology of any of the signs/symptoms observed.Present universal guidelines for diabetes mellitus type 2 (T2D) management encourage preliminary changes in lifestyle (i.e., exercise and diet). Metformin is favored and prescribed as a first-line anti-diabetes treatment for diagnosed individuals who do not show contraindications to the drug. After commencing this treatment, patients’ glycemic targets ought to be assessed after three to six months. For suboptimal blood glucose level control (target glycated hemoglobin [HbA1c]) (Laiteerapong et al., 2019), dual combination treatment is commenced. This, or other subsequent treatment modifications, must be followed by another test of glycemic targets three months later, and regularly after that, for ascertaining whether or not therapeutic goals for the patient are being accomplished, and whether there is a need for further alteration or intensification of treatment (Davies et al., 2018).Gliclazide can improve beta-cell results as well, when compared with other sulfonylureas, suggested by increased duration before the need for insulin therapy commencement as against treatment with glibenclamide (mean time from diabetes onset in case of gliclazide treatment: 27.7 years; 95% CI: 24.7–30.7; mean time in case of glibenclamide: 21.4 years; 95% CI: 18.7–24.2; p140 mg/dl (7.8 mmol/l). Fasting blood sugar levels of 11.8 mmol/L in the patient, with a prior diabetes diagnosis, has been linked to a greater risk of mortality and complications (Corsino et al., 2017).c. Why does insulin therapy lead to weight gain, and why would this be problematic for a patient with diabetes? (200 words) (15 marks)Type 2 diabetics on insulin therapy gain weight, a tendency apparent in insulin-naïve patients commencing insulin treatment as well as insulin users are intensifying treatment due to having poor glycemic control.
The above phenomenon is extensively recorded and described. The chief weight gain related risk factor among insulin-administered patients is HbA1c or average blood sugar levels before insulin therapy commencement. Higher pre-treatment HbA1c level implies greater pre-treatment glycosuria and, consequently, more weight gain following treatment commencement. Roughly 12 months after commencing insulin therapy, insulin dosage begins to influence weight gain to some extent. However, it is found to be roughly four times less influential as compared to pre-therapy HbA1c levels. Weight gain hasn’t been…

[…… parts of this paper are missing, click here to view the entire document ]

…(Angelidi et al., 2018).c. Mr. Keen should stop taking propranolol and commence valsartan 80mg/day.The use of ?-blockers among type 2 diabetics and those with established CV (cardiovascular) risk factors have been linked to elevated risks of serious hypoglycemia and CV events. Propranolol and other ?-blockers might work protectively through lowering acute hypertension, CV events, and hypoglycemia-linked cardiac arrhythmias. But ?-blockers in themselves have the potential to increase acute hypoglycemia risks. Moreover, they can dampen initial warning signs, resulting in hypoglycemia unawareness, besides causing weight gain that can, with time, exacerbate CV event risk. Valsartan might be prescribed/administered along with other medications for heart failure. But the triple-drug combination of a mineralocorticoid receptor antagonist /? -blocker, ACE inhibitor, and valsartan is discouraged (Hackethal, 2018).d. Mr. Keen should stop taking corticosteroids and instead start taking methotrexate 15mg once a week.As Mr. Keen suffers from T2D, continued corticosteroid usage will probably result in increased blood sugar levels. In the case of a significant increase in blood sugar levels, Mr. Keen may have to modify or increase his medication to achieve optimal levels. MTX or methotrexate is an extraordinary medicine with an important role in managing RA (rheumatoid arthritis) at all stages of evolution. Some of its positive qualities are great general efficacy for symptoms and signs, inhibited structural harm, and function preservation with controllable and acceptable safety, yet-to-be-rivaled cost-efficacy, a large dosage-titratable range, and options for administering either parenterally or orally (Taylor et al., 2019).e. Mr. Keen should stop taking St John’s Wort and instead seek psychotherapy for his depression.St. John’s Wort possesses a hyperforin element, a separate part of its phytochemical and molecular structure, inducing CYP3A4. Also, the medication is a PXR (pregnane X receptor) agonist, which activates the p-glycoprotein and PXR receptor, besides modifying the pharmacokinetics of several other drugs. This point must be borne in mind as roughly three in ten liver-metabolized medications are dependent on this PRX receptor (Wick, 2016). Another efficient therapy is psychotherapy, alone, or combined with medications. Its benefits include a lasting impact that safeguards against symptoms that recur even following….....

Show More ⇣


     Open the full completed essay and source list


OR

     Order a one-of-a-kind custom essay on this topic


Related Essays

Provider Patient Communication Through Professional Interpreters

communication and results in better health outcomes. Through a study that was carried out a sample of 40 elderly Hispanic diabetic patients at a Wellness Center in Los Angeles, using a professional interpreter improves provider-patient communication. The use of professional interpreters and language concordance is associated with improved provider-patient interactions, enhanced interpersonal care, and better medication adherence within three months. Keywords: elderly Hispanics, patients, medication adherence, bilingual interpreters, treatment, patient-provider communication, healthcare providers. Overview Provider-patient communication is an important factor in enhancing patient outcomes in the modern healthcare environment. Elderly Hispanic immigrants and Mexican Americans are among patient populations facing relatively high rates of diabetes. Sentell & Braun (2012) contend… Continue Reading...

Diabetes and Self Care

prone to diabetes stress regarded as clinically significant. Diabetes distress severely affects adult diabetic patients with a poor diabetes management plan. Such patients stand a high risk of diabetes-related complications. These developments are linked to poor glycemic control and self-management (Leeet al, 2018). The current research seeks to establish whether autonomy support by the health supporters of patients such as the members of their family has a relationship with the glycemic control for 12 months., and if it acts as a buffer in the relationship between high levels of diabetic distress and the glycemic control that follows. The focus of the study is… Continue Reading...

sample essay writing service

Cite This Resource:

Latest APA Format (6th edition)

Copy Reference
"Diabetic Patient" (2020, April 28) Retrieved July 3, 2025, from
https://www.aceyourpaper.com/essays/diabetic-patient-2176977

Latest MLA Format (8th edition)

Copy Reference
"Diabetic Patient" 28 April 2020. Web.3 July. 2025. <
https://www.aceyourpaper.com/essays/diabetic-patient-2176977>

Latest Chicago Format (16th edition)

Copy Reference
"Diabetic Patient", 28 April 2020, Accessed.3 July. 2025,
https://www.aceyourpaper.com/essays/diabetic-patient-2176977